Table 3 Estimated Kaplan–Meier events rates of 4-year follow-up
Adverse events | Overall population | Propensity score-matched population | ||||||
|---|---|---|---|---|---|---|---|---|
High AIP (n = 937) | Low AIP (n = 1419) | Adjusted HRa (95% CI) | P Value | High AIP (n = 821) | Low AIP (n = 821) | HR (95% CI) | P value | |
MACCE | 253 (27.0) | 230 (16.2) | 1.638 (1.363–1.969) | < 0.001 | 214 (26.1) | 145 (17.7) | 1.614 (1.303–2.001) | < 0.001 |
All-cause death | 40 (4.3) | 33 (2.3) | 1.690 (1.049–2.724) | 0.031 | 34 (4.1) | 21 (2.6) | 1.750 (1.003–3.054) | 0.049 |
Cardiac death | 28 (3.0) | 19 (1.3) | 2.184 (1.197–3.984) | 0.011 | 24 (2.9) | 11 (1.3) | 2.615 (1.251–5.470) | 0.011 |
Cardiac death/MI | 71 (7.58) | 50 (3.52) | 2.199 (1.531–3.158) | < 0.001 | 58 (7.06) | 30 (3.65) | 1.968 (1.266–3.058) | 0.003 |
MI | 58 (6.3) | 41 (2.9) | 1.962 (1.301–2.960) | 0.001 | 47 (5.8) | 25 (3.1) | 2.080 (1.267–3.415) | 0.004 |
Repeat revascularization | 210 (22.9) | 190 (13.5) | 1.644 (1.343–2.013) | < 0.001 | 177 (22.0) | 119 (14.6) | 1.628 (1.285–2.062) | < 0.001 |
TVR | 125 (13.6) | 99 (7.0) | 1.768 (1.347–2.322) | < 0.001 | 105 (13.1) | 60 (7.4) | 1.809 (1.310–2.498) | < 0.001 |
Non-TVR | 85 (9.4) | 91 (6.5) | 1.413 (1.043–1.916) | 0.026 | 72 (9.0) | 59 (7.3) | 1.314 (0.927–1.865) | 0.125 |
Stroke | 23 (2.5) | 27 (1.9) | 1.124 (0.628–2.014) | 0.694 | 20 (2.5) | 17 (2.1) | 1.191 (0.610–2.325) | 0.608 |